Literature DB >> 16673293

Hepatocellular carcinoma and hepatitis B virus.

Henry Lik-Yuen Chan1, Joseph Jao-Yiu Sung.   

Abstract

Chronic hepatitis B is the most common cause of hepatocellular carcinoma (HCC) in Asia. Integration of hepatitis B virus (HBV) genome is likely an early event of carcinogenesis. The integrated HBV genome may activate neighboring cellular genes directly to offer a selective growth advantage to the liver cells. Production of hepatitis B X protein can act as a transactivator on various cellular genes for tumor development. Hepatic inflammation and cirrhosis also favors the process of carcinogenesis. Various viral factors associated with hepatocellular carcinoma development include HBV genotype, basal core promoter mutations, and high viral load. Polymorphisms at the androgen receptor-regulating genes and cytokine genes are possible host factors associated with HCC. This review article summarizes the pathogenesis of HBV-related carcinogenesis and the viral and host factors that may increase the risk of HCC development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16673293     DOI: 10.1055/s-2006-939753

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  57 in total

1.  Hepatitis B prevention and control: Lessons from the East and the West.

Authors:  Monica C Robotin
Journal:  World J Hepatol       Date:  2011-02-27

Review 2.  Oxidative stress and antioxidants in hepatic pathogenesis.

Authors:  Hye-Lin Ha; Hye-Jun Shin; Mark A Feitelson; Dae-Yeul Yu
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 3.  Hepatitis B virus-induced oncogenesis.

Authors:  Joachim Lupberger; Eberhard Hildt
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

4.  The preS deletion of hepatitis B virus (HBV) is associated with liver fibrosis progression in patients with chronic HBV infection.

Authors:  Fan Li; Xiaodong Li; Tao Yan; Yan Liu; Yongqian Cheng; Zhihui Xu; Qing Shao; Hao Liao; Pengyu Huang; Jin Li; Guo-Feng Chen; Dongping Xu
Journal:  Hepatol Int       Date:  2018-04-12       Impact factor: 6.047

Review 5.  Molecular classification and novel targets in hepatocellular carcinoma: recent advancements.

Authors:  Yujin Hoshida; Sara Toffanin; Anja Lachenmayer; Augusto Villanueva; Beatriz Minguez; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

6.  Antiviral drug resistance testing in patients with chronic hepatitis B.

Authors:  Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Chi-Hang Tse; Lilly K W Yuen; Hoi-Yun Chan; Stephen A Locarnini; Henry Lik-Yuen Chan
Journal:  Dig Dis Sci       Date:  2011-07-09       Impact factor: 3.199

7.  Cryo-electron microscopy of hepatitis B virions reveals variability in envelope capsid interactions.

Authors:  Stefan Seitz; Stephan Urban; Christoph Antoni; Bettina Böttcher
Journal:  EMBO J       Date:  2007-08-30       Impact factor: 11.598

Review 8.  Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China.

Authors:  Rui Yu; Rong Fan; Jinlin Hou
Journal:  Front Med       Date:  2014-05-08       Impact factor: 4.592

9.  Interferon-alpha restrains growth and invasive potential of hepatocellular carcinoma induced by hepatitis B virus X protein.

Authors:  Jian-Qing Yang; Guang-Dong Pan; Guang-Ping Chu; Zhen Liu; Qiang Liu; Yi Xiao; Lin Yuan
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

10.  Association between MDM2-SNP309 and hepatocellular carcinoma in Taiwanese population.

Authors:  Jyh-Der Leu; I-Feng Lin; Ying-Fang Sun; Su-Mei Chen; Chih-Chao Liu; Yi-Jang Lee
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.